CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,023,010
- in 6 filings, $3.0M under 10b5-1 plans
Net −$3,023,010. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Barrow Robert −$1.9M Chief Executive Officer sold 2% of stake
- Sullivan Mark −$514K Chief Legal Officer sold 3% of stake
- Karlin Daniel −$397K Chief Medical Officer sold 1% of stake
- Roberts Brandi −$123K Chief Financial Officer sold <1% of stake
- Wiley Matthew T. −$113K Chief Commercial Officer sold <1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-26 | Karlin Dan Chief Medical Officer | Shares withheld for taxes | −118,143 | $1.21 | $143K | 3,168,757 |
| 2022-02-15 | Barrow Robert Chief Executive Officer | Shares withheld for taxes | −18,734 | $1.35 | $25K | 2,225,979 |
| 2022-02-10 | Liao Carrie VP, Controller&Acct Principal | Grant or award | +403,430 | 403,430 | ||
| 2022-02-10 | Liao Carrie VP, Controller&Acct Principal | Grant or award · Stock Option (Right to Buy) | +524,450 | 524,450 | ||
| 2022-01-15 | Barrow Robert Chief Executive Officer | Shares withheld for taxes | −190,287 | $1.05 | $200K | 2,244,713 |
Page 12 of 12 · 225 trades